![]() |
市场调查报告书
商品编码
1547534
全球口腔薄膜市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测Global Oral Thin Films Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球口腔薄膜市场需求预计将从 2023 年的 39.9 亿美元增至 2032 年的近 92.9 亿美元,2024-2032 年研究期间复合年增长率为 9.85%。
口腔薄膜是用于药物传递的薄而柔韧的薄膜,可溶解在口腔黏膜中,从而快速起效并增强药物的生物利用度。口服薄膜剂主要用于不能服用固体形式药物的老年、儿童和卧床患者。因此,製药公司正大力研发将现有药物转为速溶口服薄膜药物。此外,口腔薄膜的应用不仅限于口腔系统,也扩展到胃滞留和舌下给药系统的应用。因此,製药业正致力于缩短药物开发时间和高效的药物传输平台。此外,对高效药物传输技术和药物运输便利性的需求不断增长,这在最近推动了市场的发展。
口腔膜剂由亲水性聚合物组成,在舌头或口腔中快速溶解,与液体接触时透过溶解将药物输送到体循环。口服薄膜有几个优点:起效快、易于运输、绕过肝臟首过效应和易于操作。此外,它们还具有较高的生物利用度和药物的快速吸收。因此,舌下口腔薄膜是片剂的更好替代品,因为它提供完整的药物传递以快速缓解症状。此外,吞嚥困难的人需要口服药物。因此,为了快速口服药物而开发了口服薄膜药物。为了提高患者的依从性,市场参与者开发了各种类型的疫苗和荷尔蒙。使用口腔薄膜来防止酸敏感药物胃肠道降解将推动全球市场。然而,口腔薄膜治疗的昂贵成本、大量研究投资的需求以及与药物开发相关的挑战正在阻碍全球市场的成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球口腔薄膜市场的各个细分市场进行了包容性评估。口腔薄膜产业的成长和趋势为本研究提供了整体方法。
口腔薄膜市场报告的这一部分提供了国家和地区层面细分市场的详细资料,从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲口腔薄膜市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。口腔薄膜市场的主要参与者包括Aquestive Therapeutics Inc.、CL Pharm、Cure Pharmaceutical、Dr. Reddy'S Laboratories、Indivior Plc、IntelGenx Corp.、Kyu Kyu Pharmaceutical Co. Ltd.、DK Livkon Pvt.。有限公司、NAL Pharma、Seoul Pharma Co. Ltd.、Shilpa Therapeutics Pvt. Ltd.有限公司、Sunovion Pharmaceuticals Inc.、以星实验室有限公司。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Oral Thin Films Market is presumed to reach the market size of nearly USD 9.29 Billion by 2032 from USD 3.99 Billion in 2023 with a CAGR of 9.85% under the study period 2024-2032.
Oral thin films are thin, flexible films used for drug delivery that dissolve in the oral mucosa resulting in the rapid onset of action and enhanced bioavailability for drugs. The oral thin films are mainly used for geriatric, pediatric, and bedridden patients who cannot intake the solid form of the medicine. Therefore, the pharmaceutical companies are carrying out remarkable R&D to switch their existing drugs in the fast dissolving oral thin films drugs. Moreover, the application of oral thin films is not limited to buccal systems but also expands in the applications of gastroretentive and sublingual delivery systems. Therefore, the pharmaceutical industry is concentrating on shortening drug development timelines and efficient drug delivery platforms. Moreover, there is a growing demand for efficient drug delivery techniques and convenience in the transportation of the drug, which has fuelled the market in the recent past.
The oral film is made up of hydrophilic polymers that quickly dissolves on the tongue or buccal cavity, delivering the drug to the systemic circulation via dissolution when contact with liquid is made. Oral thin films have several advantages: the fast onset of action, ease of transportation, bypassing hepatic first-pass effect, and handling. In addition, these offer high bioavailability and rapid absorption for drugs. Therefore, the sublingual oral thin film is a better alternative for tablets, as it provides complete drug delivery for quick relief. Besides, people with swallowing difficulty require oral administration of drugs. Therefore, oral thin film medication is developed for swift oral administration of medicines. To improve patient compliance, various types of vaccines and hormones are developed by the market players. The use of oral thin films for preventing gastrointestinal degradation of acid-sensitive drugs will drive the global market. However, the expensive cost of treatments involving oral thin films, the requirement of vast research investment, and challenges related to drug development are hampering the market growth at the global level.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oral Thin Films. The growth and trends of Oral Thin Films industry provide a holistic approach to this study.
This section of the Oral Thin Films market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Oral Thin Films market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oral Thin Films market include Aquestive Therapeutics Inc., C.L. Pharm, Cure Pharmaceutical, Dr. Reddy'S Laboratories, Indivior Plc, IntelGenx Corp., Kyu Kyu Pharmaceutical Co. Ltd., DK Livkon Pvt. Ltd., NAL Pharma, Seoul Pharma Co. Ltd., Shilpa Therapeutics Pvt. Ltd., Sunovion Pharmaceuticals Inc., ZIM Laboratories Limited. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.